Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Crosbie

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Lung Cancer (Amsterdam, Netherlands)|April 27, 2017
Research letter: Evaluating the future pathological N descriptors for lung cancer staging in a UK populationTim Edwards, Haval Balata, Philip Foden, et al.
Fish & Shellfish Immunology|May 27, 2008
Serological evidence of an antibody response in farmed southern bluefin tuna naturally infected with the blood fluke Cardicola forsteriHamish M Aiken, Craig J Hayward, Philip Crosbie, et al.
Diagnostic and Prognostic Research|February 18, 2026
The continuous net benefit: assessing the clinical utility of prediction models when informing a continuum of decisionsJose Benitez-Aurioles, Laure Wynants, Niels Peek, et al.
Veterinary Immunology and Immunopathology|December 5, 2012
Effect of immunization route on mucosal and systemic immune response in Atlantic salmon (Salmo salar)Victoria A Valdenegro-Vega, Philip Crosbie, Benita Vincent, et al.
Fish & Shellfish Immunology|March 26, 2015
Vaccination with recombinant protein (r22C03), a putative attachment factor of Neoparamoeba perurans, against AGD in Atlantic salmon (Salmo salar) and implications of a co-infection with Yersinia ruckeriVictoria A Valdenegro-Vega, Mathew Cook, Philip Crosbie, et al.
British Journal of Cancer|August 24, 2016
How should performance in EBUS mediastinal staging in lung cancer be measured?Matthew Evison, Philip Crosbie, Neal Navani, et al.
International Journal for Parasitology|August 17, 2005
Changes in antigenic profile during culture of Neoparamoeba sp., causative agent of amoebic gill disease in Atlantic salmonMargarita Villavedra, Kristy McCarthy, Joyce To, et al.
Fish & Shellfish Immunology|November 30, 2014
Effects of single and repeated infections with Neoparamoeba perurans on antibody levels and immune gene expression in Atlantic salmon (Salmo salar)Victoria A Valdenegro-Vega, Mark Polinski, Andrew Bridle, et al.
Haematologica|November 20, 2023
Pilot study of lung cancer screening for survivors of Hodgkin lymphomaRachel Broadbent, Philip Crosbie, Christopher J Armitage, et al.
Thorax|May 6, 2016
EBUS-guided mediastinal lung cancer staging: monitoring of quality standards improves performanceMatthew Evison, Philip Crosbie, Julie Martin, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Lung Cancer (Amsterdam, Netherlands)|April 27, 2017
Research letter: Evaluating the future pathological N descriptors for lung cancer staging in a UK populationTim Edwards, Haval Balata, Philip Foden, et al.
Fish & Shellfish Immunology|May 27, 2008
Serological evidence of an antibody response in farmed southern bluefin tuna naturally infected with the blood fluke Cardicola forsteriHamish M Aiken, Craig J Hayward, Philip Crosbie, et al.
Diagnostic and Prognostic Research|February 18, 2026
The continuous net benefit: assessing the clinical utility of prediction models when informing a continuum of decisionsJose Benitez-Aurioles, Laure Wynants, Niels Peek, et al.
Veterinary Immunology and Immunopathology|December 5, 2012
Effect of immunization route on mucosal and systemic immune response in Atlantic salmon (Salmo salar)Victoria A Valdenegro-Vega, Philip Crosbie, Benita Vincent, et al.
Fish & Shellfish Immunology|March 26, 2015
Vaccination with recombinant protein (r22C03), a putative attachment factor of Neoparamoeba perurans, against AGD in Atlantic salmon (Salmo salar) and implications of a co-infection with Yersinia ruckeriVictoria A Valdenegro-Vega, Mathew Cook, Philip Crosbie, et al.
British Journal of Cancer|August 24, 2016
How should performance in EBUS mediastinal staging in lung cancer be measured?Matthew Evison, Philip Crosbie, Neal Navani, et al.
International Journal for Parasitology|August 17, 2005
Changes in antigenic profile during culture of Neoparamoeba sp., causative agent of amoebic gill disease in Atlantic salmonMargarita Villavedra, Kristy McCarthy, Joyce To, et al.
Fish & Shellfish Immunology|November 30, 2014
Effects of single and repeated infections with Neoparamoeba perurans on antibody levels and immune gene expression in Atlantic salmon (Salmo salar)Victoria A Valdenegro-Vega, Mark Polinski, Andrew Bridle, et al.
Haematologica|November 20, 2023
Pilot study of lung cancer screening for survivors of Hodgkin lymphomaRachel Broadbent, Philip Crosbie, Christopher J Armitage, et al.
Thorax|May 6, 2016
EBUS-guided mediastinal lung cancer staging: monitoring of quality standards improves performanceMatthew Evison, Philip Crosbie, Julie Martin, et al.
Pageof 4